Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.03256596 |
2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.31022143 |
3 | negative regulation of cell killing (GO:0031342) | 5.31022143 |
4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.03104796 |
5 | positive regulation by symbiont of host defense response (GO:0052509) | 4.97791593 |
6 | modulation by symbiont of host defense response (GO:0052031) | 4.97791593 |
7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.97791593 |
8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.97791593 |
9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.97791593 |
10 | modulation by symbiont of host immune response (GO:0052553) | 4.97791593 |
11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.62392406 |
12 | detection of molecule of bacterial origin (GO:0032490) | 4.39923648 |
13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.39323618 |
14 | positive thymic T cell selection (GO:0045059) | 4.35978621 |
15 | regulation of gamma-delta T cell activation (GO:0046643) | 4.35663574 |
16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.33126035 |
17 | negative T cell selection (GO:0043383) | 4.26090272 |
18 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.24836768 |
19 | detection of other organism (GO:0098543) | 4.22804123 |
20 | negative regulation of T cell mediated immunity (GO:0002710) | 4.22690790 |
21 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.14173880 |
22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.12775103 |
23 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.12775103 |
24 | leukocyte aggregation (GO:0070486) | 4.12742559 |
25 | negative thymic T cell selection (GO:0045060) | 4.09822219 |
26 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.00791316 |
27 | tolerance induction (GO:0002507) | 3.98460166 |
28 | detection of external biotic stimulus (GO:0098581) | 3.97960771 |
29 | neutrophil activation involved in immune response (GO:0002283) | 3.93568774 |
30 | T cell migration (GO:0072678) | 3.91161527 |
31 | detection of bacterium (GO:0016045) | 3.87486150 |
32 | interferon-gamma production (GO:0032609) | 3.86223849 |
33 | immunoglobulin mediated immune response (GO:0016064) | 3.84554469 |
34 | positive T cell selection (GO:0043368) | 3.83990965 |
35 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.77733071 |
36 | response to muramyl dipeptide (GO:0032495) | 3.77359054 |
37 | positive regulation of B cell differentiation (GO:0045579) | 3.75181654 |
38 | regulation of regulatory T cell differentiation (GO:0045589) | 3.74069700 |
39 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.73518821 |
40 | positive regulation of interferon-alpha production (GO:0032727) | 3.72162526 |
41 | response to peptidoglycan (GO:0032494) | 3.70830290 |
42 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.68392227 |
43 | macrophage activation involved in immune response (GO:0002281) | 3.61368201 |
44 | regulation of interferon-alpha production (GO:0032647) | 3.61357962 |
45 | positive regulation of granulocyte differentiation (GO:0030854) | 3.61336699 |
46 | positive regulation of antigen processing and presentation (GO:0002579) | 3.54488294 |
47 | response to type I interferon (GO:0034340) | 3.53397760 |
48 | macrophage activation (GO:0042116) | 3.52021433 |
49 | detection of biotic stimulus (GO:0009595) | 3.48644521 |
50 | cellular response to type I interferon (GO:0071357) | 3.48583550 |
51 | type I interferon signaling pathway (GO:0060337) | 3.48583550 |
52 | T cell selection (GO:0045058) | 3.47013867 |
53 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.46674469 |
54 | thymic T cell selection (GO:0045061) | 3.46670260 |
55 | negative regulation of interleukin-12 production (GO:0032695) | 3.46210111 |
56 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.45016434 |
57 | NIK/NF-kappaB signaling (GO:0038061) | 3.44269370 |
58 | cellular extravasation (GO:0045123) | 3.44079735 |
59 | regulation of T cell tolerance induction (GO:0002664) | 3.40662297 |
60 | neutrophil mediated immunity (GO:0002446) | 3.40011050 |
61 | myeloid cell activation involved in immune response (GO:0002275) | 3.38404555 |
62 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.34639304 |
63 | germinal center formation (GO:0002467) | 3.34489265 |
64 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.31915603 |
65 | respiratory burst (GO:0045730) | 3.30727682 |
66 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.29031823 |
67 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.29031823 |
68 | response to host immune response (GO:0052572) | 3.28318999 |
69 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.28318999 |
70 | regulation of B cell differentiation (GO:0045577) | 3.26639697 |
71 | mast cell activation (GO:0045576) | 3.26617066 |
72 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.23849380 |
73 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.21846993 |
74 | dendritic cell migration (GO:0036336) | 3.21756564 |
75 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.21541381 |
76 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.19231357 |
77 | myeloid leukocyte mediated immunity (GO:0002444) | 3.18355917 |
78 | modulation by symbiont of host cellular process (GO:0044068) | 3.17576004 |
79 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.16738584 |
80 | neutrophil activation (GO:0042119) | 3.16243879 |
81 | microglial cell activation (GO:0001774) | 3.16018055 |
82 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.14014110 |
83 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.13612525 |
84 | positive regulation of mast cell activation (GO:0033005) | 3.13528996 |
85 | dendritic cell chemotaxis (GO:0002407) | 3.13139091 |
86 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.13038719 |
87 | B cell receptor signaling pathway (GO:0050853) | 3.11922676 |
88 | activated T cell proliferation (GO:0050798) | 3.11508984 |
89 | regulation of antigen processing and presentation (GO:0002577) | 3.10369326 |
90 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.10055954 |
91 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.09330479 |
92 | response to host (GO:0075136) | 3.09330479 |
93 | response to host defenses (GO:0052200) | 3.09330479 |
94 | leukocyte cell-cell adhesion (GO:0007159) | 3.09247894 |
95 | pinocytosis (GO:0006907) | 3.08130422 |
96 | negative regulation of granulocyte differentiation (GO:0030853) | 3.07658153 |
97 | B cell mediated immunity (GO:0019724) | 3.06073603 |
98 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.06071904 |
99 | myeloid dendritic cell activation (GO:0001773) | 3.05545064 |
100 | granulocyte activation (GO:0036230) | 3.05509696 |
101 | leukocyte degranulation (GO:0043299) | 3.00168955 |
102 | negative regulation of adaptive immune response (GO:0002820) | 2.98815967 |
103 | mature B cell differentiation (GO:0002335) | 2.97130987 |
104 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.96888370 |
105 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.96499025 |
106 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.92841022 |
107 | regulation of mast cell degranulation (GO:0043304) | 2.91921977 |
108 | response to interleukin-15 (GO:0070672) | 2.91774595 |
109 | defense response to protozoan (GO:0042832) | 2.91242640 |
110 | positive regulation of isotype switching (GO:0045830) | 2.90822633 |
111 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.90019117 |
112 | natural killer cell mediated immunity (GO:0002228) | 2.90019117 |
113 | * antigen receptor-mediated signaling pathway (GO:0050851) | 2.88779839 |
114 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.88719814 |
115 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.87425773 |
116 | hepatocyte apoptotic process (GO:0097284) | 2.87058721 |
117 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.86241279 |
118 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.86241279 |
119 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.86093119 |
120 | B cell homeostasis (GO:0001782) | 2.85327708 |
121 | cellular response to interferon-beta (GO:0035458) | 2.83251429 |
122 | positive regulation of interferon-beta production (GO:0032728) | 2.82623494 |
123 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.82145806 |
124 | positive regulation of tolerance induction (GO:0002645) | 2.81575630 |
125 | response to protozoan (GO:0001562) | 2.81473994 |
126 | * T cell receptor signaling pathway (GO:0050852) | 2.80969615 |
127 | regulation of tolerance induction (GO:0002643) | 2.80725446 |
128 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.79357393 |
129 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.78302401 |
130 | modulation by virus of host process (GO:0019054) | 2.78208453 |
131 | positive regulation of B cell mediated immunity (GO:0002714) | 2.76431049 |
132 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.76431049 |
133 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.72124388 |
134 | cellular response to interleukin-15 (GO:0071350) | 2.71182483 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.27933802 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.98578335 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.93917157 |
4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.43611220 |
5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.33393964 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.74455442 |
7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.64269150 |
8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.63678073 |
9 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.63209399 |
10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.44361494 |
11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.30613282 |
12 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.13177911 |
13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.99170259 |
14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.92126498 |
15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.84094966 |
16 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.82170700 |
17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.80896424 |
18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.73217817 |
19 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.59004595 |
20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.56700478 |
21 | * MYB_26560356_Chip-Seq_TH2_Human | 2.45334170 |
22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.45093772 |
23 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.43806009 |
24 | MAF_26560356_Chip-Seq_TH1_Human | 2.31876020 |
25 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.28325180 |
26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.26963871 |
27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.24266697 |
28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.23993264 |
29 | MYB_26560356_Chip-Seq_TH1_Human | 2.18269078 |
30 | MYC_22102868_ChIP-Seq_BL_Human | 2.16247645 |
31 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.16243488 |
32 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.12113809 |
33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.11329551 |
34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.01942627 |
35 | UTX_26944678_Chip-Seq_JUKART_Human | 2.01555215 |
36 | SPI1_23127762_ChIP-Seq_K562_Human | 1.99664845 |
37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.92937359 |
38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.82703505 |
39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81601697 |
40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81461170 |
41 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.76108434 |
42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.73823174 |
43 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.72029877 |
44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.69832462 |
45 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.66793584 |
46 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.65014173 |
47 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.63694564 |
48 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.59242985 |
49 | MAF_26560356_Chip-Seq_TH2_Human | 1.57417278 |
50 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.57272210 |
51 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.52305915 |
52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.50550868 |
53 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45198017 |
54 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.41026554 |
55 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36255583 |
56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.35000114 |
57 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34961701 |
58 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34079880 |
59 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.31577124 |
60 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27862464 |
61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.27593025 |
62 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.22743027 |
63 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20371216 |
64 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.18962929 |
65 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17308408 |
66 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16459643 |
67 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.16095413 |
68 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14713883 |
69 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14576986 |
70 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13214565 |
71 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11692478 |
72 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11158674 |
73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.08752944 |
74 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.08203311 |
75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07332944 |
76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06064654 |
77 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.05554061 |
78 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04693723 |
79 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.03100126 |
80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02768461 |
81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00734899 |
82 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96869255 |
83 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.93420994 |
84 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93386068 |
85 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93071705 |
86 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.91888514 |
87 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.91568530 |
88 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.91306971 |
89 | GATA1_22025678_ChIP-Seq_K562_Human | 0.91257382 |
90 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.90518487 |
91 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.86455174 |
92 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.85893296 |
93 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.85462392 |
94 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.82566361 |
95 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.82287644 |
96 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.82278762 |
97 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.78114981 |
98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.77735706 |
99 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75464879 |
100 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.74399080 |
101 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73292997 |
102 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.70913286 |
103 | GATA2_19941826_ChIP-Seq_K562_Human | 0.70829446 |
104 | GATA3_26560356_Chip-Seq_TH1_Human | 0.70532691 |
105 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.70012341 |
106 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.67106276 |
107 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.66875400 |
108 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65807998 |
109 | GATA1_19941826_ChIP-Seq_K562_Human | 0.65586968 |
110 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.65482359 |
111 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.65266382 |
112 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.64799680 |
113 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.64299280 |
114 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64278541 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.98002880 |
2 | MP0005671_abnormal_response_to | 3.39983650 |
3 | MP0003436_decreased_susceptibility_to | 3.11147272 |
4 | MP0000685_abnormal_immune_system | 3.00576995 |
5 | MP0005000_abnormal_immune_tolerance | 2.90750003 |
6 | MP0001800_abnormal_humoral_immune | 2.90509090 |
7 | MP0003763_abnormal_thymus_physiology | 2.84255909 |
8 | MP0009785_altered_susceptibility_to | 2.80078819 |
9 | MP0005387_immune_system_phenotype | 2.79771242 |
10 | MP0001790_abnormal_immune_system | 2.79771242 |
11 | MP0002419_abnormal_innate_immunity | 2.74795994 |
12 | MP0000569_abnormal_digit_pigmentation | 2.74780449 |
13 | MP0006082_CNS_inflammation | 2.71743140 |
14 | MP0005025_abnormal_response_to | 2.70947766 |
15 | MP0002452_abnormal_antigen_presenting | 2.69243755 |
16 | MP0003303_peritoneal_inflammation | 2.65322949 |
17 | * MP0002723_abnormal_immune_serum | 2.63008038 |
18 | MP0002148_abnormal_hypersensitivity_rea | 2.62779679 |
19 | * MP0001819_abnormal_immune_cell | 2.48973376 |
20 | * MP0002420_abnormal_adaptive_immunity | 2.48726002 |
21 | MP0005058_abnormal_lysosome_morphology | 2.45197433 |
22 | MP0003724_increased_susceptibility_to | 2.42254207 |
23 | MP0005464_abnormal_platelet_physiology | 2.39880752 |
24 | MP0002396_abnormal_hematopoietic_system | 2.27885473 |
25 | MP0002405_respiratory_system_inflammati | 2.23477528 |
26 | MP0004510_myositis | 2.22001935 |
27 | MP0002166_altered_tumor_susceptibility | 2.19582206 |
28 | * MP0002398_abnormal_bone_marrow | 2.16713701 |
29 | MP0009278_abnormal_bone_marrow | 2.11600853 |
30 | MP0009333_abnormal_splenocyte_physiolog | 2.10620304 |
31 | MP0005174_abnormal_tail_pigmentation | 2.09804810 |
32 | MP0003300_gastrointestinal_ulcer | 2.08386151 |
33 | MP0004947_skin_inflammation | 2.07235986 |
34 | * MP0000716_abnormal_immune_system | 2.01224303 |
35 | MP0003172_abnormal_lysosome_physiology | 1.97328881 |
36 | MP0001873_stomach_inflammation | 1.90798442 |
37 | MP0010155_abnormal_intestine_physiology | 1.90689440 |
38 | MP0000689_abnormal_spleen_morphology | 1.88684734 |
39 | MP0001853_heart_inflammation | 1.87117531 |
40 | MP0002006_tumorigenesis | 1.87116877 |
41 | MP0002722_abnormal_immune_system | 1.82050015 |
42 | MP0001845_abnormal_inflammatory_respons | 1.76792581 |
43 | MP0001545_abnormal_hematopoietic_system | 1.72928016 |
44 | MP0005397_hematopoietic_system_phenotyp | 1.72928016 |
45 | * MP0000703_abnormal_thymus_morphology | 1.67241074 |
46 | MP0001533_abnormal_skeleton_physiology | 1.66231235 |
47 | * MP0002429_abnormal_blood_cell | 1.65684652 |
48 | MP0004808_abnormal_hematopoietic_stem | 1.60295477 |
49 | MP0005451_abnormal_body_composition | 1.51651645 |
50 | MP0004883_abnormal_blood_vessel | 1.51281986 |
51 | MP0000015_abnormal_ear_pigmentation | 1.50552056 |
52 | MP0003448_altered_tumor_morphology | 1.49581159 |
53 | MP0000465_gastrointestinal_hemorrhage | 1.46916205 |
54 | MP0008469_abnormal_protein_level | 1.45158421 |
55 | MP0000858_altered_metastatic_potential | 1.44725084 |
56 | MP0002933_joint_inflammation | 1.38840451 |
57 | MP0005310_abnormal_salivary_gland | 1.38555053 |
58 | MP0003866_abnormal_defecation | 1.31292847 |
59 | MP0002998_abnormal_bone_remodeling | 1.25107512 |
60 | MP0000490_abnormal_crypts_of | 1.21394599 |
61 | MP0001851_eye_inflammation | 1.16807465 |
62 | MP0005075_abnormal_melanosome_morpholog | 1.13176337 |
63 | MP0002277_abnormal_respiratory_mucosa | 1.10137342 |
64 | MP0003183_abnormal_peptide_metabolism | 1.08944323 |
65 | MP0009764_decreased_sensitivity_to | 1.08076964 |
66 | MP0003191_abnormal_cellular_cholesterol | 1.05881935 |
67 | MP0000343_altered_response_to | 1.05662203 |
68 | MP0005164_abnormal_response_to | 1.05174986 |
69 | MP0003690_abnormal_glial_cell | 1.02773765 |
70 | MP0004130_abnormal_muscle_cell | 1.01861187 |
71 | MP0002009_preneoplasia | 0.97566957 |
72 | MP0008004_abnormal_stomach_pH | 0.97565394 |
73 | MP0010307_abnormal_tumor_latency | 0.96658568 |
74 | MP0005076_abnormal_cell_differentiation | 0.96473709 |
75 | MP0004381_abnormal_hair_follicle | 0.95578948 |
76 | MP0009840_abnormal_foam_cell | 0.91227430 |
77 | MP0003787_abnormal_imprinting | 0.89653636 |
78 | MP0003828_pulmonary_edema | 0.89010363 |
79 | MP0009763_increased_sensitivity_to | 0.87754826 |
80 | MP0000371_diluted_coat_color | 0.87198525 |
81 | MP0003075_altered_response_to | 0.83248091 |
82 | MP0000604_amyloidosis | 0.77153262 |
83 | MP0005166_decreased_susceptibility_to | 0.76971579 |
84 | MP0005023_abnormal_wound_healing | 0.76598718 |
85 | MP0002019_abnormal_tumor_incidence | 0.75993783 |
86 | MP0005390_skeleton_phenotype | 0.75146105 |
87 | MP0002095_abnormal_skin_pigmentation | 0.74549164 |
88 | MP0004484_altered_response_of | 0.72532541 |
89 | MP0010352_gastrointestinal_tract_polyps | 0.71677897 |
90 | MP0002138_abnormal_hepatobiliary_system | 0.70402304 |
91 | MP0002132_abnormal_respiratory_system | 0.68934354 |
92 | MP0003045_fibrosis | 0.67847167 |
93 | MP0000249_abnormal_blood_vessel | 0.67805978 |
94 | MP0003453_abnormal_keratinocyte_physiol | 0.67285041 |
95 | MP0003795_abnormal_bone_structure | 0.67184833 |
96 | MP0001663_abnormal_digestive_system | 0.63032463 |
97 | MP0003656_abnormal_erythrocyte_physiolo | 0.61514066 |
98 | MP0003221_abnormal_cardiomyocyte_apopto | 0.61343370 |
99 | MP0008874_decreased_physiological_sensi | 0.60994800 |
100 | MP0003693_abnormal_embryo_hatching | 0.59822963 |
101 | MP0003566_abnormal_cell_adhesion | 0.58879258 |
102 | MP0008007_abnormal_cellular_replicative | 0.58459636 |
103 | MP0003091_abnormal_cell_migration | 0.56901451 |
104 | MP0009765_abnormal_xenobiotic_induced | 0.55800125 |
105 | MP0002332_abnormal_exercise_endurance | 0.54306076 |
106 | MP0003077_abnormal_cell_cycle | 0.53163383 |
107 | MP0000313_abnormal_cell_death | 0.53160856 |
108 | MP0002136_abnormal_kidney_physiology | 0.52428689 |
109 | MP0001986_abnormal_taste_sensitivity | 0.51872243 |
110 | MP0008057_abnormal_DNA_replication | 0.51158300 |
111 | MP0008260_abnormal_autophagy | 0.50690768 |
112 | MP0000609_abnormal_liver_physiology | 0.50333270 |
113 | MP0006054_spinal_hemorrhage | 0.47493202 |
114 | MP0005376_homeostasis/metabolism_phenot | 0.46452108 |
115 | MP0002693_abnormal_pancreas_physiology | 0.46269885 |
116 | MP0002133_abnormal_respiratory_system | 0.46167551 |
117 | MP0001191_abnormal_skin_condition | 0.45868116 |
118 | MP0001243_abnormal_dermal_layer | 0.45866562 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 6.16067140 |
2 | Eczematoid dermatitis (HP:0000976) | 5.58723847 |
3 | Recurrent bacterial skin infections (HP:0005406) | 5.54167408 |
4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.04092173 |
5 | Stomatitis (HP:0010280) | 4.62712429 |
6 | Recurrent fungal infections (HP:0002841) | 4.62178834 |
7 | Recurrent viral infections (HP:0004429) | 4.30283863 |
8 | Myositis (HP:0100614) | 4.28940625 |
9 | T lymphocytopenia (HP:0005403) | 4.09710263 |
10 | Abnormality of T cell number (HP:0011839) | 3.95837089 |
11 | Pustule (HP:0200039) | 3.95037926 |
12 | Mediastinal lymphadenopathy (HP:0100721) | 3.91104431 |
13 | Recurrent skin infections (HP:0001581) | 3.89180886 |
14 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.89144382 |
15 | Abnormality of macrophages (HP:0004311) | 3.76563657 |
16 | Autoimmune thrombocytopenia (HP:0001973) | 3.61247392 |
17 | Recurrent cutaneous fungal infections (HP:0011370) | 3.59400889 |
18 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.59400889 |
19 | Retrobulbar optic neuritis (HP:0100654) | 3.55788398 |
20 | Optic neuritis (HP:0100653) | 3.55788398 |
21 | Obstructive lung disease (HP:0006536) | 3.54945926 |
22 | Chronic obstructive pulmonary disease (HP:0006510) | 3.54945926 |
23 | Orchitis (HP:0100796) | 3.54423270 |
24 | Systemic lupus erythematosus (HP:0002725) | 3.53157639 |
25 | Leukocytosis (HP:0001974) | 3.46970391 |
26 | Severe combined immunodeficiency (HP:0004430) | 3.45033212 |
27 | Gingivitis (HP:0000230) | 3.44682610 |
28 | Eosinophilia (HP:0001880) | 3.43682975 |
29 | Chest pain (HP:0100749) | 3.29765752 |
30 | Vacuolated lymphocytes (HP:0001922) | 3.22961204 |
31 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.21590099 |
32 | Panhypogammaglobulinemia (HP:0003139) | 3.19285148 |
33 | Combined immunodeficiency (HP:0005387) | 3.14171512 |
34 | Abnormality of T cells (HP:0002843) | 3.13823471 |
35 | Periodontitis (HP:0000704) | 3.13086771 |
36 | Thyroiditis (HP:0100646) | 3.10153954 |
37 | Granulocytopenia (HP:0001913) | 3.09638976 |
38 | Abnormality of eosinophils (HP:0001879) | 3.08250345 |
39 | Vasculitis (HP:0002633) | 3.03330299 |
40 | Meningitis (HP:0001287) | 3.00239683 |
41 | IgM deficiency (HP:0002850) | 2.98858137 |
42 | Chronic otitis media (HP:0000389) | 2.96283742 |
43 | Abnormality of the fingertips (HP:0001211) | 2.95350644 |
44 | Prostate neoplasm (HP:0100787) | 2.90309437 |
45 | Inflammation of the large intestine (HP:0002037) | 2.83609708 |
46 | Increased cerebral lipofuscin (HP:0011813) | 2.83150586 |
47 | Spontaneous hematomas (HP:0007420) | 2.79276211 |
48 | Pulmonary embolism (HP:0002204) | 2.78345582 |
49 | Prolonged bleeding time (HP:0003010) | 2.77365499 |
50 | Nasal polyposis (HP:0100582) | 2.70557631 |
51 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.70310310 |
52 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.70061577 |
53 | Peritonitis (HP:0002586) | 2.67009735 |
54 | Anorexia (HP:0002039) | 2.65509459 |
55 | Gastrointestinal inflammation (HP:0004386) | 2.65313569 |
56 | Gingival bleeding (HP:0000225) | 2.62709441 |
57 | Abnormal platelet volume (HP:0011876) | 2.61985157 |
58 | Glomerulonephritis (HP:0000099) | 2.60232554 |
59 | Pulmonary infiltrates (HP:0002113) | 2.51742409 |
60 | Hemoptysis (HP:0002105) | 2.49992153 |
61 | B lymphocytopenia (HP:0010976) | 2.49524502 |
62 | Abnormality of B cell number (HP:0010975) | 2.49524502 |
63 | Recurrent bronchitis (HP:0002837) | 2.49319886 |
64 | Hypochromic microcytic anemia (HP:0004840) | 2.49313095 |
65 | Chronic diarrhea (HP:0002028) | 2.48206841 |
66 | Epistaxis (HP:0000421) | 2.47849998 |
67 | Petechiae (HP:0000967) | 2.47420047 |
68 | Gangrene (HP:0100758) | 2.46553673 |
69 | Cellulitis (HP:0100658) | 2.43455640 |
70 | Abnormality of the prostate (HP:0008775) | 2.43443613 |
71 | Colitis (HP:0002583) | 2.40932279 |
72 | Hypochromic anemia (HP:0001931) | 2.40292689 |
73 | Purpura (HP:0000979) | 2.39385313 |
74 | Increased IgE level (HP:0003212) | 2.38691255 |
75 | Episodic fever (HP:0001954) | 2.38191745 |
76 | Arterial thrombosis (HP:0004420) | 2.35203602 |
77 | Slow saccadic eye movements (HP:0000514) | 2.33743744 |
78 | Abnormality of the nasal mucosa (HP:0000433) | 2.33501780 |
79 | Disinhibition (HP:0000734) | 2.33015400 |
80 | Cheilitis (HP:0100825) | 2.32705096 |
81 | Abnormality of T cell physiology (HP:0011840) | 2.31641261 |
82 | IgG deficiency (HP:0004315) | 2.30508151 |
83 | Hematochezia (HP:0002573) | 2.29858112 |
84 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.27177624 |
85 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.27177624 |
86 | Abnormality of glycolipid metabolism (HP:0010969) | 2.27177624 |
87 | Autoimmune hemolytic anemia (HP:0001890) | 2.26351926 |
88 | Encephalitis (HP:0002383) | 2.25799687 |
89 | Microcytic anemia (HP:0001935) | 2.25740028 |
90 | Abnormal platelet function (HP:0011869) | 2.25335958 |
91 | Impaired platelet aggregation (HP:0003540) | 2.25335958 |
92 | Urticaria (HP:0001025) | 2.22939567 |
93 | Acute hepatic failure (HP:0006554) | 2.22889663 |
94 | Thick nail (HP:0001805) | 2.22524221 |
95 | Dysostosis multiplex (HP:0000943) | 2.21927910 |
96 | Lymphopenia (HP:0001888) | 2.21278841 |
97 | Basal ganglia calcification (HP:0002135) | 2.20071440 |
98 | Keratoconjunctivitis sicca (HP:0001097) | 2.19541349 |
99 | Abnormality of the pleura (HP:0002103) | 2.18307026 |
100 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.16292869 |
101 | Hypoplasia of the thymus (HP:0000778) | 2.13202641 |
102 | Thrombocytosis (HP:0001894) | 2.12996983 |
103 | Agnosia (HP:0010524) | 2.12558708 |
104 | Glomerulopathy (HP:0100820) | 2.11242985 |
105 | Osteomyelitis (HP:0002754) | 2.11218150 |
106 | Menorrhagia (HP:0000132) | 2.11160881 |
107 | Vertigo (HP:0002321) | 2.09107020 |
108 | Sepsis (HP:0100806) | 2.07909998 |
109 | Increased mean platelet volume (HP:0011877) | 2.06673685 |
110 | Abnormality of the endocardium (HP:0004306) | 2.05397474 |
111 | Abnormality of the peritoneum (HP:0002585) | 2.02840889 |
112 | Papilledema (HP:0001085) | 2.00087093 |
113 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.00077070 |
114 | Verrucae (HP:0200043) | 1.98863260 |
115 | Papilloma (HP:0012740) | 1.98863260 |
116 | Keratoconjunctivitis (HP:0001096) | 1.98413439 |
117 | Hepatosplenomegaly (HP:0001433) | 1.97718323 |
118 | Keratitis (HP:0000491) | 1.97106844 |
119 | Recurrent pneumonia (HP:0006532) | 1.96808025 |
120 | Amaurosis fugax (HP:0100576) | 1.96154052 |
121 | Increased IgM level (HP:0003496) | 1.95420906 |
122 | Agammaglobulinemia (HP:0004432) | 1.94307164 |
123 | Viral hepatitis (HP:0006562) | 1.94153179 |
124 | Amyloidosis (HP:0011034) | 1.93715825 |
125 | Hypergammaglobulinemia (HP:0010702) | 1.92989679 |
126 | Lymphoma (HP:0002665) | 1.92849112 |
127 | Joint swelling (HP:0001386) | 1.92320331 |
128 | Skin ulcer (HP:0200042) | 1.92314141 |
129 | Myocardial infarction (HP:0001658) | 1.91309967 |
130 | Urethral obstruction (HP:0000796) | 1.89758817 |
131 | Gastrointestinal infarctions (HP:0005244) | 1.89531965 |
132 | Stomach cancer (HP:0012126) | 1.88065531 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 4.46910948 |
2 | MAP4K1 | 4.38669065 |
3 | TYK2 | 3.42175129 |
4 | IKBKE | 3.04117443 |
5 | MAP3K14 | 2.97262986 |
6 | IRAK4 | 2.76166405 |
7 | JAK3 | 2.64465884 |
8 | BLK | 2.59854871 |
9 | KIT | 2.57320389 |
10 | IRAK3 | 2.57123366 |
11 | ZAP70 | 2.54042209 |
12 | TBK1 | 2.51150417 |
13 | RIPK4 | 2.27649429 |
14 | JAK1 | 2.10541122 |
15 | ITK | 1.96196785 |
16 | TGFBR2 | 1.94795260 |
17 | STK10 | 1.92090080 |
18 | IKBKB | 1.84305626 |
19 | TAOK3 | 1.83466112 |
20 | FGFR4 | 1.82301702 |
21 | PRPF4B | 1.74895547 |
22 | TEC | 1.73614205 |
23 | HCK | 1.72848373 |
24 | * LCK | 1.61181972 |
25 | MAP3K13 | 1.60336969 |
26 | CSK | 1.59402141 |
27 | CSF1R | 1.56725442 |
28 | SYK | 1.56054840 |
29 | NME2 | 1.50775565 |
30 | FES | 1.49806723 |
31 | BTK | 1.45265964 |
32 | FGFR3 | 1.39916661 |
33 | CHUK | 1.29300234 |
34 | BMPR2 | 1.27015227 |
35 | PIK3CG | 1.25547442 |
36 | SIK2 | 1.25259389 |
37 | CAMKK2 | 1.25036080 |
38 | RPS6KA4 | 1.21171087 |
39 | CDK12 | 1.20483017 |
40 | CLK1 | 1.18535191 |
41 | PIM1 | 1.16605275 |
42 | MAP3K3 | 1.12558305 |
43 | MAP3K1 | 1.06627918 |
44 | JAK2 | 1.06542382 |
45 | MARK3 | 1.04037448 |
46 | * LYN | 1.02328707 |
47 | KSR2 | 0.99063951 |
48 | MAP3K2 | 0.96491020 |
49 | PIM2 | 0.95869511 |
50 | TAOK1 | 0.95518122 |
51 | NEK9 | 0.90548406 |
52 | MAP3K10 | 0.89375529 |
53 | STK4 | 0.87171097 |
54 | MAP3K11 | 0.86960812 |
55 | NLK | 0.85620421 |
56 | PTK2B | 0.85052873 |
57 | EPHB1 | 0.84543529 |
58 | TLK1 | 0.83702147 |
59 | GRK6 | 0.82851838 |
60 | MAP2K3 | 0.82793521 |
61 | CAMK1D | 0.80586396 |
62 | ERN1 | 0.79156821 |
63 | MARK2 | 0.77531103 |
64 | CDK6 | 0.77160297 |
65 | CAMKK1 | 0.75460107 |
66 | GRK7 | 0.72686523 |
67 | PRKCQ | 0.68301653 |
68 | YES1 | 0.67466442 |
69 | WNK1 | 0.64126209 |
70 | SGK3 | 0.62619816 |
71 | RAF1 | 0.62006491 |
72 | CAMK1G | 0.61061614 |
73 | SGK2 | 0.58109215 |
74 | PDPK1 | 0.54759192 |
75 | IRAK1 | 0.54350997 |
76 | EIF2AK2 | 0.53686093 |
77 | CDK4 | 0.53351107 |
78 | MAP3K6 | 0.52387249 |
79 | MAP3K5 | 0.51938623 |
80 | EEF2K | 0.49581564 |
81 | NUAK1 | 0.49008026 |
82 | CDC42BPA | 0.48612696 |
83 | NEK2 | 0.48584781 |
84 | FGR | 0.47795132 |
85 | GRK5 | 0.47140198 |
86 | RET | 0.46408977 |
87 | HIPK2 | 0.45644086 |
88 | PTK6 | 0.45476578 |
89 | RPS6KA5 | 0.45045161 |
90 | CDK9 | 0.43799105 |
91 | KDR | 0.43582880 |
92 | ACVR1B | 0.43049923 |
93 | KSR1 | 0.42510617 |
94 | TNK2 | 0.42402606 |
95 | PDGFRB | 0.42142171 |
96 | MAP2K6 | 0.42061047 |
97 | RPS6KA6 | 0.41936098 |
98 | ATR | 0.41726193 |
99 | MAPKAPK2 | 0.41472234 |
100 | FLT3 | 0.41390349 |
101 | PRKD2 | 0.41026179 |
102 | STK11 | 0.40937872 |
103 | TTN | 0.40507324 |
104 | TAOK2 | 0.40146347 |
105 | TRPM7 | 0.40049694 |
106 | LRRK2 | 0.40041292 |
107 | EPHA3 | 0.39821943 |
108 | STK38 | 0.39576886 |
109 | BRD4 | 0.39487816 |
110 | ABL1 | 0.39056603 |
111 | MAPK11 | 0.38993226 |
112 | MAPK7 | 0.38751281 |
113 | SIK3 | 0.38077095 |
114 | * EGFR | 0.37948686 |
115 | PDK1 | 0.36381756 |
116 | PKN2 | 0.36181764 |
117 | DYRK1B | 0.35162349 |
118 | PRKCD | 0.35045994 |
119 | PBK | 0.34770310 |
120 | IRAK2 | 0.33913858 |
121 | FRK | 0.33251730 |
122 | MAPK4 | 0.32867946 |
123 | MST4 | 0.32622627 |
124 | TESK2 | 0.32561258 |
125 | RPS6KL1 | 0.32212280 |
126 | RPS6KC1 | 0.32212280 |
127 | MAPK12 | 0.31717071 |
128 | DMPK | 0.29884923 |
129 | MATK | 0.29300094 |
130 | * FYN | 0.28142263 |
131 | MAP3K7 | 0.27327994 |
132 | PRKCH | 0.27194539 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.03379577 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.89190002 |
3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.81508146 |
4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.66430557 |
5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.61628962 |
6 | Measles_Homo sapiens_hsa05162 | 2.58486771 |
7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.46403572 |
8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.24243919 |
9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.21559743 |
10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.20208360 |
11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.20079140 |
12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.15804473 |
13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.10266153 |
14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.08414422 |
15 | Allograft rejection_Homo sapiens_hsa05330 | 2.07256629 |
16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.04890745 |
17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.03466066 |
18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.95993812 |
19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.95053366 |
20 | Pertussis_Homo sapiens_hsa05133 | 1.76357680 |
21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.75442156 |
22 | Influenza A_Homo sapiens_hsa05164 | 1.72885145 |
23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.66530295 |
24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.65730876 |
25 | Asthma_Homo sapiens_hsa05310 | 1.63425882 |
26 | Tuberculosis_Homo sapiens_hsa05152 | 1.61874744 |
27 | Malaria_Homo sapiens_hsa05144 | 1.61047463 |
28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.60893063 |
29 | Legionellosis_Homo sapiens_hsa05134 | 1.55198161 |
30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.54298824 |
31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54198754 |
32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.44765782 |
33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.44007013 |
34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.40099419 |
35 | Hepatitis B_Homo sapiens_hsa05161 | 1.38241560 |
36 | Apoptosis_Homo sapiens_hsa04210 | 1.38216165 |
37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.38015202 |
38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.27521969 |
39 | Shigellosis_Homo sapiens_hsa05131 | 1.25700314 |
40 | Lysosome_Homo sapiens_hsa04142 | 1.23803571 |
41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.20922536 |
42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.18004635 |
43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.15197055 |
44 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.13513510 |
45 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.11264866 |
46 | Hepatitis C_Homo sapiens_hsa05160 | 1.10103419 |
47 | Salmonella infection_Homo sapiens_hsa05132 | 1.07104549 |
48 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.04991894 |
49 | Platelet activation_Homo sapiens_hsa04611 | 0.96786770 |
50 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.95304322 |
51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89417371 |
52 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.87236004 |
53 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.87080364 |
54 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86735198 |
55 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.80972917 |
56 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.80744438 |
57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80666734 |
58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.79021340 |
59 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75436844 |
60 | Ribosome_Homo sapiens_hsa03010 | 0.74644540 |
61 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74627233 |
62 | HTLV-I infection_Homo sapiens_hsa05166 | 0.73704090 |
63 | Phagosome_Homo sapiens_hsa04145 | 0.72180121 |
64 | Endometrial cancer_Homo sapiens_hsa05213 | 0.69703603 |
65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69002574 |
66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67479013 |
67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.66574761 |
68 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.66428736 |
69 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.65324959 |
70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64407497 |
71 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.64193759 |
72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.62099680 |
73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60366900 |
74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59928695 |
75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59409385 |
76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57240432 |
77 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.54798535 |
78 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51987295 |
79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51426300 |
80 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50830044 |
81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.50318271 |
82 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48992930 |
83 | Homologous recombination_Homo sapiens_hsa03440 | 0.48919722 |
84 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48780619 |
85 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.47758754 |
86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47528024 |
87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45867145 |
88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45386331 |
89 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.45192139 |
90 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.44663111 |
91 | Long-term potentiation_Homo sapiens_hsa04720 | 0.44606855 |
92 | Colorectal cancer_Homo sapiens_hsa05210 | 0.44073648 |
93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43855617 |
94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.43399341 |
95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41971258 |
96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39917225 |
97 | Base excision repair_Homo sapiens_hsa03410 | 0.39411765 |
98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39372700 |
99 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38960252 |
100 | Glioma_Homo sapiens_hsa05214 | 0.38896278 |
101 | DNA replication_Homo sapiens_hsa03030 | 0.38281892 |
102 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.37759867 |
103 | Amoebiasis_Homo sapiens_hsa05146 | 0.37725640 |
104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37722635 |
105 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.37098288 |
106 | Endocytosis_Homo sapiens_hsa04144 | 0.36847702 |
107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35004314 |
108 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.34986973 |
109 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34686663 |
110 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.33642428 |
111 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.32250841 |
112 | ABC transporters_Homo sapiens_hsa02010 | 0.31577851 |
113 | Lysine degradation_Homo sapiens_hsa00310 | 0.31468727 |
114 | Prostate cancer_Homo sapiens_hsa05215 | 0.30258757 |
115 | Insulin resistance_Homo sapiens_hsa04931 | 0.27592271 |
116 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.25323341 |
117 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.24893961 |
118 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.24666986 |
119 | Spliceosome_Homo sapiens_hsa03040 | 0.23851799 |
120 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.23254794 |
121 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.22976290 |